Background: With increased rate of permanent pacemaker’s (PPM) implantation, the rate of complication also increased many folds. Infection in pacemakers is one of the dreaded complications which need a multidisciplinary approach in its management. Methods: All patients with permanent pacemakers, who presented with infection of device, were admitted in our unit. The infected device was explanted and wound left open. The same device was used as a temporary pacemaker with a new PPM screwing lead from internal jugular approach. Once the infection was under control, a new device was implanted on the other side and temporary wire (PPM screwing lead) pulled out. Wound on both side closed and patient kept on antibiotics for a week. Results: Total 10 cases of infected device received. Single chambers devices with infection were six and dual chamber pacemakers were four. One case with infection had tine lead and nine patients presented with screwing leads. Male and female ratio was 2.3:1. All leads were explanted in our department with conventional gadgets using rotation and traction maneuvers. Culture sensitivity in all cases remained negative. Patients were kept on broad spectrum antibiotics till the wound was clear. One patient had small pericardial effusion soon after explantation of tine lead, which was treated conservatively. No other major or minor complication documented. Conclusion: Scrupulous planning and preparation before system extraction and later on new Cardiac implantable electronic device re-implantation is essential for better patient outcome. Keywords: Cardiac implantable electronic device; Permanent pacemaker; PPM; Internal jugular approach; Temporary pacemaker; TPM

Author Biographies

Bakhawar Shah, Hayat Abad Medical Complex Peshawar


Cheragh Hussain, Hayat Abad Medical Complex Peshawar

Hayat Abad Medical Complex Peshawar


Zhan C, Baine WB, Sedrakyan A, Steiner C. Cardiac device implantation in the United States from 1997 through 2004: a population-based analysis. J Gen Intern Med 2008;23(Suppl 1):13–9.

Calvi V, Conti S, Pruiti GP, Capodanno D, Puzzangara E, Tempio D, et al. Incidence rate and predictors of permanent pacemaker implantation after transcatheter aortic valve implantation with self-expanding CoreValve prosthesis. J Interv Card Electrophysiol 2012;34(2):189–95.

Kirkfeldt RE, Johansen JB, Nohr EA, Jørgensen OD, Nielsen JC. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J 2014;35(18):1186–94.

Fernandes A, Cassandra M, Trigo J, Nascimento J, Carmo Cachulo M, Providência R, et al. Cardiac device infection: Review based in the experience of a single center. Rev Port Cardiol 2016;35(6):351–8.

Sastry S, Rahman R, Yassin MH Cardiac Implantable Electronic Device Infection: From an Infection Prevention Perspective. Adv Prev Med 2015;2015:357087.

Dye C. After 2015: infectious diseases in a new era of health and development. Philos Trans R Soc Lond B Biol Sci 2014;369(1645):20130426.

Tarakji KG, Ellis CR, Defaye P, Kennergren C. Cardiac Implantable Electronic Device Infection in Patients at Risk. Arrhythm Electrophysiol Rev 2016;5(1):65–71.

Kirkfeldt RE, Johansen JB, Nielsen JC. Management of Cardiac Electronic Infections: Challenges and Outcomes. Device Arrhythm Electrophysiol Rev 2016;5(3):183–7.

Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation 2010;121(3):458–77.

Sekiguchi Y. Conservative therapy for the management of cardiac implantable electronic device infection. J Arrhythm 2016;32(4):293–6.

Viganego F, O'Donoghue S, Eldadah Z, Shah MH, Rastogi M, Mazel JA, et al. Effect of early diagnosis and treatment with percutaneous lead extraction on survival in patients with cardiac device infections. Am J Cardiol 2012;109(10):1466–71.

Kossaify A. Temporary Endocavitary Pacemakers and their Use and Misuse: the Least is Better. Clin Med Insights Cardiol 2014;8:9–11.

Shah B, Awan ZA. Temporary pace makers implantation: do we need fluoroscopy? J Ayub Med Coll Abbottabad 2015;27(2):284–6.

Deharo JC, Quatre A, Mancini J, Khairy P, Le Dolley Y, Casalta JP, et al. Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study. Heart 2012;98(9):724–31.

Glikson M. Conservative treatment of pacemaker pocket infection: is it a viable option? Europace 2013;15(4):474–5.

Lopez JA. Conservative management of infected pacemaker and implantable defibrillator sites with a closed antimicrobial irrigation system. Europace 2013;15(4):541–5.

Pichlmaier M, Knigina L, Kutschka I, Bara C, Oswald H, Klein G, et al. Complete removal as a routine treatment for any cardiovascular implantable electronic device-associated infection. J Thorac Cardiovasc Surg 2011;15(9):1287–91.

López Ayerbe J, Villuendas Sabaté R, García García C, Rodríguez Leor O, Gómez Pérez M, Curós Abadal A, et al. [Temporary pacemakers: current use and complications]. Rev Esp Cardiol 2004;57(11):1045–52.

Ramalingam R, Patil SS, Ananthakrishna R, Nanjappa MC. Pacemaker lead-straight through the heart. BMJ Case Rep 2011;2011:bcr0920114775.

McCann P. A review of temporary cardiac pacing wires. Indian Pacing Electrophysiol J 2007;7(1):40–9.

Betts TR. Regional survey of temporary transvenous pacing procedures and complications. Postgrad Med J 2003;79(934):463–5.

Kawata H, Pretorius V, Phan H, Mulpuru S, Gadiyaram V, Patel J, et al. Utility and safety of temporary pacing using active fixation leads and externalized reusablepermanent pacemakers after lead extraction. Europace 2013;15(9):1287–91.